Equity · Healthcare
ARVN
NASDAQArvinas (ARVN)
The line runs 9 USD on 12 August through 6.76 USD on 9 November, on a scale from 6 to 10. Days the market did not trade hold the previous close, flat.
- Market cap
- 442.7M USD
- Revenue, year to Dec 2025
- 262.6M USD
- EPS, diluted, year to Dec 2025
- −1.14 USD
- 52-week range
- 6.40 USD – 14 USD
- Avg volume
- 59.8K
as of Nov 9, 2026
Have Arvinas (ARVN) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, Arvinas insiders reported 1 open-market sale and no purchases (SEC Form 4); none has bought on the open market since 6 Mar 2026.
Form 4, 90 days to 10 Nov 2026, newest reported trade 9 Nov 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 09 Nov 2026 | Loomis David KVP, Chief Accounting Officer | Sell | 232 | 1K USD |
Which funds hold Arvinas (ARVN)?
9 of the 45 institutional funds we track reported a Arvinas position for the quarter ended 30 Jun 2026 — a combined 70.5M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| D. E. Shaw & Co. | Held (±25%) | 3,495,153 | 29.0M USD | −3.9% |
| Two Sigma Investments | Added | 2,573,447 | 21.4M USD | +40.5% |
| Citadel Advisors | Trimmed | 620,973 | 5.2M USD | −47.4% |
| AQR Capital Management | Added | 601,873 | 5.0M USD | +111.1% |
| Millennium Management | Held (±25%) | 574,011 | 4.8M USD | −0.4% |
| Man Group | Added | 256,104 | 2.1M USD | +181.5% |
| Renaissance Technologies | New position | 215,345 | 1.8M USD | |
| Point72 Asset Management | Trimmed | 141,266 | 1.2M USD | −38.5% |
| Balyasny Asset Management | New position | 6,273 | 52K USD | |
| Marshall Wace | Exited |
What has been filed or recorded for Arvinas (ARVN)?
The filings we hold for Arvinas, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.82 USD | |
| 30 Sep 2026 | Financials | Total assets | 607.5M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 513.8M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 2.58 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.90 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −1.14 USD | Revenue $263M |
| 31 Dec 2025 | Financials | Revenue | 262.6M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −80.8M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −1.14 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.48 USD | Revenue $42M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.84 USD | Revenue $22M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 1.14 USD | Revenue $189M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −2.77 USD | Revenue $263M |
What do people ask about Arvinas (ARVN)?
What did Arvinas shares close at?6.76
Arvinas closed at 6.76 USD on 9 Nov 2026, up 5.62% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Arvinas’ market cap?442.7M
Arvinas is worth 442.7M USD by market value as of 9 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Arvinas’ revenue?262.6M
Arvinas reported revenue of 262.6M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Arvinas insiders bought or sold shares recently?1 sale
In the 90 days to 10 Nov 2026, Arvinas insiders reported 1 open-market sale and no purchases (SEC Form 4); none has bought on the open market since 6 Mar 2026. See Insiders
Which funds own Arvinas?9 of 45
9 of the 45 funds we track reported a Arvinas position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were D. E. Shaw & Co., Two Sigma Investments and Citadel Advisors. See Funds
When did Arvinas last report earnings?−0.82
Arvinas last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.82 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings